Filing Details

Accession Number:
0001209191-20-059268
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-18 19:48:57
Reporting Period:
2020-11-17
Accepted Time:
2020-11-18 19:48:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674930 Fulgent Genetics Inc. FLGT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1183863 C John Bolger C/O Fulgent Genetics, Inc.
4978 Santa Anita Ave.
Temple City CA 91780
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-17 2,631 $0.38 4,644 No 4 M Direct
Common Stock Disposition 2020-11-17 4,269 $44.24 375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2020-11-17 2,631 $0.00 2,631 $0.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-04-12 No 4 M Direct
Footnotes
  1. The shares were sold in multiple transactions at prices ranging from $44.16 to $44.3784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after April 13, 2016, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.